Newtyn Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-425,000
| Closed | -$642K | – | 56 |
|
|
2023
Q1 | $642K | Sell |
425,000
-145,000
| -25% | -$219K | 0.13% | 64 |
|
|
2022
Q4 | $912K | Sell |
570,000
-230,000
| -29% | -$368K | 0.19% | 55 |
|
|
2022
Q3 | $1.16M | Sell |
800,000
-273,400
| -25% | -$396K | 0.25% | 48 |
|
|
2022
Q2 | $1.96M | Buy |
+1,073,400
| New | +$1.96M | 0.37% | 42 |
|